Secondary syphilis occurring under anti-TNFalpha therapy.
Anti-TNF agents are remarkably effective in the treatment of chronic inflammatory rheumatism diseases. Main side effect of anti-TNF is an increased risk of infection. We report the observation of a secondary syphilis occurring under anti-TNFalpha therapy.
Bories-Haffner
Clarisse
C
Département universitaire de rhumatologie, centre hospitalier et universitaire, université de Lille 2, 59037 Lille, France.
Buche
S
S
Paccou
Julien
J
D000328:Adult; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000175:diagnosis / Q000209:etiology*; D010406:Penicillins / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012307:Risk Factors; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013587:Syphilis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D010406:Penicillins; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept